The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease
Abstract
To study the putative association of dopamine agonists with sleep attacks in patients with Parkinson's disease (PD) and their relation to daytime sleepiness, we performed a survey of 2,952 PD patients in two German counties. In 177 patients, sudden, unexpected, and irresistible sleep episodes while engaged in some activity were identified in a structured telephone interview. Ninety‐one of these patients denied the occurrence of appropriate warning signs. A total of 133 patients (75%) had an Epworth Sleepiness Scale (ESS) score >10; 65 (37%) >15. Thirty‐one patients (18%) had an ESS score ≤10 and yet experienced sleep attacks without warning signs. Thus, although a significant proportion of patients at risk for sleep attacks might be identified using the ESS, roughly 1% of the PD patient population seems to be at risk for sleep attacks without appropriate warning signs and without accompanying daytime sleepiness. Sleep attacks occurred with all dopamine agonists marketed in Germany (α‐dihydroergocryptine, bromocriptine, cabergoline, lisuride, pergolide, pramipexole, ropinirole), and no significant difference between ergot and nonergot drugs was evident. Levodopa (L‐dopa) monotherapy carried the lowest risk for sleep attacks (2.9%; 95% confidence interval [CI], 1.7–4.0%) followed by dopamine agonist monotherapy (5.3%; 95% CI, 1.5–9.2%) and combination of L‐dopa and a dopamine agonist (7.3%; 95% CI, 6.1–8.5%). Neither selegeline nor amantadine or entacapone appeared to influence the occurrence of sleep attacks. A high ESS score, intake of dopamine agonists, and duration of PD were the main influencing factors for the occurrence of sleep attacks. The odds ratio for dopamine agonist therapy was 2.9 compared to 1.9 with L‐dopa therapy and 1.05 for a 1‐year‐longer disease duration. © 2003 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364
Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole
Frucht, S., Rogers, J. D., Greene, P. E., Gordon, M. F., & Fahn, S. (1999) · Neurology · doi:10.1212/wnl.52.9.1908 · Cited by 692
Hobson, D. E., Lang, A. E., Martin, W. R. W., Razmy, A., Rivest, J., & Fleming, J. (2002) · JAMA · doi:10.1001/jama.287.4.455 · Cited by 553
Sleep disorders and sleep effect in Parkinson's disease
Factor, S. A., McAlarney, T., Sanchez‐Ramos, J. R., & Weiner, W. J. (1990) · Movement Disorders · doi:10.1002/mds.870050404 · Cited by 358
Excessive daytime sleepiness and sleep benefit in Parkinson's disease: A community-based study
Tandberg, E., Larsen, J. P., & Karlsen, K. (1999) · Movement Disorders · doi:10.1002/1531-8257(199911)14:6<922::aid-mds1003>3.0.co;2-7 · Cited by 287
Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD
Rye, D. B., & Jankovic, J. (2002) · Neurology · doi:10.1212/wnl.58.3.341 · Cited by 209
Sleep attacks and Parkinson's disease treatment
Ferreira, J., Galitzky, M., Montastruc, J., & Rascol, O. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02119-x · Cited by 200
Evaluation of somnolence in Parkinson’s disease: Comparison with age- and sex-matched controls
Tan, E. K., Lum, S. Y., Fook-Chong, S. M. C., Teoh, M. L., Yih, Y., Tan, L., Tan, A., & Wong, M. C. (2002) · Neurology · doi:10.1212/wnl.58.3.465 · Cited by 169
Waking up to sleep episodes in Parkinson's Disease
Olanow, C. W., Schapira, A. H. V., & Roth, T. (2000) · Movement Disorders · doi:10.1002/1531-8257(200003)15:2<212::aid-mds1002>3.0.co;2-6 · Cited by 160
Sleep attacks (sleep episodes) with pergolide
Schapira, A. H. V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02118-8 · Cited by 130
Cited by
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
Advances in the Treatment of Prolactinomas
Gillam, M. P., Molitch, M. E., Lombardi, G., & Colao, A. (2006) · Endocrine Reviews · doi:10.1210/er.2005-9998 · Cited by 824
Non‐motor symptoms in Parkinson’s disease
Poewe, W. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02056.x · Cited by 782
Samuels, E., & Szabadi, E. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777193 · Cited by 454
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Atkin, T., Comai, S., & Gobbi, G. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014381 · Cited by 391
Metadata
- Authors
- Paus, S., Brecht, H. M., Köster, J., Seeger, G., Klockgether, T., & Wüllner, U.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2003-05-28
- Volume
- 18
- Issue
- 6
- Pages
- 659-667
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2105801762
- Cited by
- 295
- References
- 12
- FWCI
- 11.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. https://app.cochat.ai/papers/10.1002/mds.10417
- The paper
- Paus, S., Brecht, H. M., Köster, J., Seeger, G., Klockgether, T., & Wüllner, U. (2003). Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Movement Disorders. https://doi.org/10.1002/mds.10417
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.